Glenmark Pharmaceuticals' Finacea generic infringes Bayer patent - court
July 27, 2015 at 19:01 PM EDT
NEW YORK, July 27 (Reuters) - India's Glenmark Pharmaceuticals' proposed generic version of Bayer AG's Finacea, a gel for treating the common skin condition rosacea, infringes Bayer's patent, a U.S. court ruled on Monday.
